Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0000947871-25-000391·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
XTANT MED HLDGS INC
COMMON STOCK · CUSIP: 98420P308
Event date: 2025-04-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 0.00 · Class: 0.0%
- ORBIMED ROF II LLCReported CIK 0001767936
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000391
- Form type
- SCHEDULE 13D/A
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Apr 14, 2025
- Reporting period
- Apr 10, 2025
- Description
- Schedule 13D beneficial ownership